BMED vs. BALI

Last updated Jun 5, 2026

BMED (Future Health ETF) and BALI (Blackrock Advantage Large Cap Income ETF) are both exchange-traded funds - BMED is a Health & Biotech Equities fund actively managed by BlackRock, while BALI is a Derivative Income fund actively managed by BlackRock. Both are actively managed. Over the past year, BMED returned 17.59% vs 26.70% for BALI. A 0.60 correlation means they provide meaningful diversification when combined. BMED charges 0.85%/yr vs 0.35%/yr for BALI.

Performance

BMED vs. BALI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Future Health ETF (BMED) and Blackrock Advantage Large Cap Income ETF (BALI). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, BMED achieves a -5.19% return, which is significantly lower than BALI's 11.50% return.

BMED

• 1D: 1.98%
• 1M: 2.19%
• YTD: -5.19%
• 6M: -5.93%
• 1Y: 17.59%
• 3Y*: 5.91%
• 5Y*: -0.08%
• 10Y*: —

BALI

• 1D: 0.25%
• 1M: 3.94%
• YTD: 11.50%
• 6M: 12.10%
• 1Y: 26.70%
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

BMED vs. BALI - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023
BMED Future Health ETF	-5.19%	21.79%	1.55%	8.61%
BALI Blackrock Advantage Large Cap Income ETF	11.50%	14.51%	22.38%	9.52%

Correlation

The correlation between BMED and BALI is 0.54, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.54
Correlation (All Time) Calculated using the full available price history since Sep 29, 2023	0.60

The correlation between BMED and BALI has been stable across timeframes, ranging from 0.54 to 0.60 - a consistent structural relationship.

BMED vs. BALI - Sectors Allocation Comparison

Sectors	BMED	BALI
Healthcare	100.0%	9.4%
Consumer Defensive	1.5%	6.1%
Basic Materials	-	1.4%
Communication Services	-	10.6%
Consumer Cyclical	-	10.2%
Energy	-	4.3%
Financial Services	-	9.0%
Industrials	-	8.0%
Real Estate	-	0.9%
Technology	-	35.0%
Utilities	-	1.9%

Return for Risk

BMED vs. BALI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BMED

BMED Risk / Return Rank: 29
BMED Sharpe Ratio Rank: 33
BMED Sortino Ratio Rank: 33
BMED Omega Ratio Rank: 31
BMED Calmar Ratio Rank: 26
BMED Martin Ratio Rank: 24

BALI

BALI Risk / Return Rank: 84
BALI Sharpe Ratio Rank: 84
BALI Sortino Ratio Rank: 85
BALI Omega Ratio Rank: 84
BALI Calmar Ratio Rank: 79
BALI Martin Ratio Rank: 89

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BMED vs. BALI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Future Health ETF (BMED) and Blackrock Advantage Large Cap Income ETF (BALI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	BMED	BALI	Difference
Sharpe ratio: Return per unit of total volatility	1.16	2.71	-1.55
Sortino ratio: Return per unit of downside risk	1.73	3.76	-2.03
Omega ratio: Gain probability vs. loss probability	1.20	1.51	-0.30
Calmar ratio: Return relative to maximum drawdown	1.19	3.99	-2.80
Martin ratio: Return relative to average drawdown	3.00	19.95	-16.95
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

BMED vs. BALI - Sharpe Ratio Comparison

The current BMED Sharpe Ratio is 1.16, which is lower than the BALI Sharpe Ratio of 2.71. The chart below compares the historical Sharpe Ratios of BMED and BALI, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	BMED	BALI	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.16	2.71	-1.55
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.00	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.12	1.73	-1.61

Drawdowns

BMED vs. BALI - Drawdown Comparison

The maximum BMED drawdown since its inception was -36.44%, which is greater than BALI's maximum drawdown of -16.65%. Use the drawdown chart below to compare losses from any high point for BMED and BALI.

Drawdown Indicators

	BMED	BALI	Difference
Max Drawdown Largest peak-to-trough decline	-36.44%	-16.65%	-19.79%
Max Drawdown (1Y) Largest decline over 1 year	-14.85%	-6.71%	-8.14%
Max Drawdown (3Y) Largest decline over 3 years	-20.12%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-33.90%	—	—
Current Drawdown Current decline from peak	-11.17%	-0.16%	-11.01%
Average Drawdown Average peak-to-trough decline	-19.08%	-1.63%	-17.45%
Ulcer Index Depth and duration of drawdowns from previous peaks	5.88%	1.34%	+4.54%

Volatility

BMED vs. BALI - Volatility Comparison

Future Health ETF (BMED) has a higher volatility of 4.74% compared to Blackrock Advantage Large Cap Income ETF (BALI) at 1.87%. This indicates that BMED's price experiences larger fluctuations and is considered to be riskier than BALI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	BMED	BALI	Difference
Volatility (1M) Calculated over the trailing 1-month period	4.74%	1.87%	+2.87%
Volatility (6M) Calculated over the trailing 6-month period	11.23%	7.47%	+3.76%
Volatility (1Y) Calculated over the trailing 1-year period	15.23%	9.91%	+5.32%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	17.43%	12.92%	+4.51%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	17.77%	12.92%	+4.85%

BMED vs. BALI - Expense Ratio Comparison

BMED has a 0.85% expense ratio, which is higher than BALI's 0.35% expense ratio.

Dividends

BMED vs. BALI - Dividend Comparison

BMED has not paid dividends to shareholders, while BALI's dividend yield for the trailing twelve months is around 7.64%.

Position	TTM	2025	2024	2023
BALI Blackrock Advantage Large Cap Income ETF	7.64%	8.51%	7.13%	2.13%
BMED Future Health ETF	0.00%	0.00%	0.00%	0.03%

Frequently Asked Questions

Can I hold both BMED and BALI in my portfolio?

BMED and BALI have a correlation of 0.54, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, BMED or BALI?

BMED has higher volatility (4.74%) compared to BALI (1.87%). In terms of maximum drawdown, BMED dropped -36.44% vs BALI's -16.65%.

Which ETF is better, BMED or BALI?

On 1-year performance, BALI leads with 26.70% vs 17.59% for BMED. On fees, BALI is cheaper at 0.35% per year. On volatility, BALI has been the lower-risk option at 1.87%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, BMED or BALI?

Over the 1-year period, BALI has performed better with a 26.70% return vs 17.59%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, BMED or BALI?

BALI is cheaper with a 0.35% expense ratio, compared with 0.85% for BMED.

Which ETF pays a higher dividend yield, BMED or BALI?

BALI has the higher dividend yield at 7.64%, compared with 0.00% for BMED.

What is the main difference between BMED and BALI?

BMED is categorized as Health & Biotech Equities, while BALI is Derivative Income. Their fees differ too: 0.85% for BMED and 0.35% for BALI.

Which has better risk-adjusted returns?

BALI currently has the higher Sharpe Ratio (2.71 vs 1.16), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.